Is A Rise Imminent For Johnson & Johnson Stock After An 8% Fall In A Month?

Johnson & Johnson stock (NYSE: JNJ) is down 8% in a month, underperforming the broader markets, with the S&P 500 index up 6%. In a recent development, a U.S. appeals court rejected J&J’s attempted use of Texas Two-Step bankruptcy strategy to offload nearly 40,000 lawsuits for its talc products.…#johnsonjohnson #jjs #texastwostep #remicade #consumerhealthcare #eps #jnj #johnsonjohnsons #peercomparisons #vicor
Source: Reuters: Health - Category: Consumer Health News Source Type: news